Rationale and design of the Renal Lifecycle trial assessing the effect of dapagliflozin on cardiorenal outcomes in severe chronic kidney disease
W Bakker(University Medical Center Groningen), J W Rood, Ron T. Gansevoort(University Medical Center Groningen), Michael Walsh(Population Health Research Institute), Rob C.M. van Kruijsdijk(Radboud University Nijmegen), Michel P. Hermans, Alexander F.L. Later, Akin Özyilmaz, Hiddo J.L. Heerspink(University Medical Center Groningen), Christoph Wanner(Universitätsklinikum Würzburg), Paul Leurs, Joost C. van den Born(University Medical Center Groningen), Marc Vervloet(Radboud University Nijmegen), Stefan R. A. Konings, Clare Arnott(Royal Prince Alfred Hospital), Marc H. Hemmelder(Nefrovisie), Arnold H. Boonstra, Marga Eshuis, Stefan P. Berger(University Medical Center Groningen), José Luis Górriz(Universitat de València), Angela Yee‐Moon Wang(Texas State University), Arjan M. van Alphen, Alferso C Abrahams, Dirk Kuypers(KU Leuven), J J Huitema, Lily Jakulj(Dianet), S. J. J. Logtenberg, M. Gelens(Maastricht University Medical Centre), Sandrine Gaillard(University Medical Center Utrecht), Henk Boom, Jacqueline T. Jonker, J. Bayrak, Ellen K. Hoogeveen, Sunil V. Badve(UNSW Sydney), Sander W.M. Keet, Aaltje Y Adema(Medisch Centrum Leeuwarden), Willem A. Bax, Peter T Luik, Aiko P. J. de Vries(Leiden University Medical Center), Gürbey Ocak(St. Antonius Ziekenhuis), Peter van der Meer(University Medical Center Groningen), Jeroen B. van der Net(University of Oxford), EF de Maar, Yvonne De Waal, W Jansen, Nathan Brinkman, Tim C van Faassen(University Medical Center Groningen), Dennis A. Hesselink
Cited by 18
Related Papers
Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy
|New England Journal of Medicine|2019|6k
Dapagliflozin in Patients with Chronic Kidney Disease
|New England Journal of Medicine|2020|5.2k
Empagliflozin and Progression of Kidney Disease in Type 2 Diabetes
|New England Journal of Medicine|2016|3.6k
The definition, classification, and prognosis of chronic kidney disease: a KDIGO Controversies Conference report
|Kidney International|2010|2.3k
Calcineurin Inhibitor Nephrotoxicity
|Clinical Journal of the American Society of Nephrology|2009|1.5k